Aurora A kinase is required for activation of the Fanconi anemia/BRCA pathway upon DNA damage

Min Jeong Chun1, Soo Kyung Hwang1, Hyoun Geun Kim1

  • 1Cancer Cell and Molecular Biology Branch Research Institute National Cancer Center Goyang Gyeonggi Korea.

FEBS Open Bio
|July 12, 2016
PubMed

Insights

Aurora A kinase phosphorylates FANCA at S165, a crucial step for activating the Fanconi anemia (FA)/BRCA pathway. This DNA damage response mechanism is vital for repairing interstrand cross-link lesions.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • The DNA damage response (DDR) is intricately linked to cell cycle regulation and mitotic progression.
  • Mitotic kinases, including Aurora A kinase, play roles in cellular responses to DNA damage by phosphorylating key regulators.

Purpose of the Study:

  • To investigate the role of Aurora A kinase in the activation of the Fanconi anemia (FA)/BRCA pathway.
  • To determine if Aurora A kinase directly phosphorylates components of the FA/BRCA pathway.

Main Methods:

  • Co-immunoprecipitation to detect protein interactions.
  • siRNA-mediated knockdown of Aurora A kinase.
  • In vitro kinase assays.
  • Analysis of FANCD2 monoubiquitination and nuclear foci formation.
  • Site-directed mutagenesis (S165A) and analysis of cellular sensitivity to mitomycin C (MMC).

Main Results:

  • Aurora A kinase interacts with FANCA, a core component of the FA pathway.
  • Silencing Aurora A kinase inhibits FANCD2 monoubiquitination and nuclear foci formation, key markers of FA pathway activation.
  • Aurora A kinase directly phosphorylates FANCA at serine 165 (S165) in vitro.
  • MMC treatment induces S165 phosphorylation of FANCA.
  • Cells expressing a non-phosphorylatable S165A FANCA mutant show impaired FANCD2 monoubiquitination, reduced foci formation, and increased sensitivity to MMC.

Conclusions:

  • Aurora A kinase-mediated phosphorylation of FANCA at S165 is essential for the proper activation of the FA/BRCA pathway.
  • This phosphorylation event is a critical step in the cellular response to DNA interstrand cross-link lesions (ICLs).
  • Aurora A kinase represents a potential therapeutic target for enhancing DNA repair inhibition in cancer treatment.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K